Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Sugimoto

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[Medical care support intervention to the patient and family who has chosen a terminal care at home - an influence of satisfactory experience on the culture of terminal care]Kaoru Sugimoto, Mariko Ishikawa, Nobuko Kouketsu, et al.
Modern Rheumatology|December 30, 2009
Investigation of pathological and clinical features of lupus nephritis in 73 autopsied cases with systemic lupus erythematosusTakayuki Kon, Ken Yamaji, Kaoru Sugimoto, et al.
Endocrine Journal|December 14, 2018
Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytomaIchiro Abe, Hideyuki Fujii, Hanako Ohishi, et al.
Current Biology : CB|March 31, 2015
PLETHORA Genes Control Regeneration by a Two-Step MechanismAbdul Kareem, Kavya Durgaprasad, Kaoru Sugimoto, et al.
Medicine|November 26, 2019
Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parametersIchiro Abe, Kentaro Ochi, Yuichi Takashi, et al.
Modern Rheumatology|February 22, 2012
Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in JapanMichihiro Ogasawara, Michiaki Kageyama, Makio Kusaoi, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 3, 2011
Effect of various anticoagulant agents on large-volume leukocytapheresis using new Cellsorba CS-180S FilterKatsura Hohtatsu, Ken Yamaji, Risa Yamada, et al.
Drug Discoveries & Therapeutics|January 21, 2020
Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitusKaoru Sugimoto, Ichiro Abe, Midori Minezaki, et al.
Internal Medicine (Tokyo, Japan)|May 1, 2018
Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's SyndromeIchiro Abe, Kaoru Sugimoto, Tetsumasa Miyajima, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|October 11, 2012
Gene expression analysis using a high-resolution DNA microarray of peripheral whole blood immediately before and after leukocytapheresis for rheumatoid arthritisMakio Kusaoi, Ken Yamaji, Go Murayama, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[Medical care support intervention to the patient and family who has chosen a terminal care at home - an influence of satisfactory experience on the culture of terminal care]Kaoru Sugimoto, Mariko Ishikawa, Nobuko Kouketsu, et al.
Modern Rheumatology|December 30, 2009
Investigation of pathological and clinical features of lupus nephritis in 73 autopsied cases with systemic lupus erythematosusTakayuki Kon, Ken Yamaji, Kaoru Sugimoto, et al.
Endocrine Journal|December 14, 2018
Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytomaIchiro Abe, Hideyuki Fujii, Hanako Ohishi, et al.
Current Biology : CB|March 31, 2015
PLETHORA Genes Control Regeneration by a Two-Step MechanismAbdul Kareem, Kavya Durgaprasad, Kaoru Sugimoto, et al.
Medicine|November 26, 2019
Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parametersIchiro Abe, Kentaro Ochi, Yuichi Takashi, et al.
Modern Rheumatology|February 22, 2012
Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in JapanMichihiro Ogasawara, Michiaki Kageyama, Makio Kusaoi, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 3, 2011
Effect of various anticoagulant agents on large-volume leukocytapheresis using new Cellsorba CS-180S FilterKatsura Hohtatsu, Ken Yamaji, Risa Yamada, et al.
Drug Discoveries & Therapeutics|January 21, 2020
Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitusKaoru Sugimoto, Ichiro Abe, Midori Minezaki, et al.
Internal Medicine (Tokyo, Japan)|May 1, 2018
Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's SyndromeIchiro Abe, Kaoru Sugimoto, Tetsumasa Miyajima, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|October 11, 2012
Gene expression analysis using a high-resolution DNA microarray of peripheral whole blood immediately before and after leukocytapheresis for rheumatoid arthritisMakio Kusaoi, Ken Yamaji, Go Murayama, et al.
Pageof 4